CRISPR Therapeutics’ $280 Million Equity Issuance

Walder Wyss advised CRISPR Therapeutics on the issuance.CRISPR Therapeutics AG (NASDAQ: CRSP), a Switzerland-based biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, completed…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Marco Zingaro

This content is for Standard 1 Year members only.
Login Join Now